GPAT-IN-1

CAS No. 1204347-51-2

GPAT-IN-1( —— )

Catalog No. M37313 CAS No. 1204347-51-2

GPAT-IN-1 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor, which can be used to study obesity and diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 70 In Stock
10MG 101 In Stock
25MG 164 In Stock
50MG 238 In Stock
100MG 352 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GPAT-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    GPAT-IN-1 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor, which can be used to study obesity and diabetes.
  • Description
    GPAT-IN-1 is a glycerol-3-phosphate acyltransferase (GPAT) inhibitor with an IC50 value of 8.9 μM. GPAT-IN-1 can be used for the research of obesity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Transferase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1204347-51-2
  • Formula Weight
    423.95
  • Molecular Formula
    C21H26ClNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C=1C=C(C=CC1NS(=O)(=O)CCCCCCCC)C2=CC=CC(Cl)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Outlaw VK, et al. Design, Synthesis, and Evaluation of 4- and 5-Substituted o-(Octanesulfonamido)benzoic Acids as Inhibitors of Glycerol-3-Phosphate Acyltransferase. Medchemcomm. 2014;5(6):826-830.?
molnova catalog
related products
  • AZD3988

    AZD3988 is an orally active and highly potent inhibitor of diacylglycerol acyltransferase-1 (DGAT-1) for the study of diabetes and obesity.

  • OU749

    OU749 is a γ-glutamyl transferase (GGT) inhibitor with an intrinsic Ki of 17.6 μM.

  • Hydroprotopine

    Hydroprotopine, treatment for coronary heart disease and angina, and the treatment effect is remarkable.